Lab-Grown mini tumors could personalize liver cancer treatment after surgery
NCT ID NCT07363356
First seen Jan 24, 2026 · Last updated May 22, 2026 · Updated 15 times
Summary
This study tests a new way to choose cancer drugs after liver cancer surgery. Doctors will grow a mini version of a patient's tumor in the lab and test different drugs on it to find the most effective one. The goal is to lower the chance of cancer coming back. The trial will enroll 56 adults with liver cancer who have high-risk features after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA RESECTABLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
the Third Affiliated Hospital of Naval Medical University, Shanghai, Shanghai 200433/201805
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.